(S)-Cdc7-IN-18
Modify Date: 2024-01-10 17:53:59
(S)-Cdc7-IN-18 structure
|
Common Name | (S)-Cdc7-IN-18 | ||
|---|---|---|---|---|
| CAS Number | 2562329-13-7 | Molecular Weight | 367.47 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H21N5OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (S)-Cdc7-IN-18(S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1)[1]. |
| Name | (S)-Cdc7-IN-18 |
|---|
| Description | (S)-Cdc7-IN-18 is a potent inhibitor of CDC7. Overexpression of huCdc7 promotes overactivation of MCM2, an important marker of tumor cells, and thus promotes aberrant proliferation of tumor cells. (S)-Cdc7-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2020239107A1, compound 1-1)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Gang Li, et al. Tetracyclines as Cdc7 inhibitors. Patent WO2020239107A1. |
| Molecular Formula | C19H21N5OS |
|---|---|
| Molecular Weight | 367.47 |